{"id":89526,"date":"2026-04-15T09:00:36","date_gmt":"2026-04-15T09:00:36","guid":{"rendered":"https:\/\/imatsolutions.com\/?p=89526"},"modified":"2026-04-14T19:35:36","modified_gmt":"2026-04-14T19:35:36","slug":"cms-medicare-advantage-star-ratings-overhaul","status":"publish","type":"post","link":"https:\/\/imatsolutions.com\/index.php\/2026\/04\/cms-medicare-advantage-star-ratings-overhaul\/","title":{"rendered":"CMS Medicare Advantage Star Ratings Overhaul: What It Means for Data, Quality, and Performance"},"content":{"rendered":"

By Mark Coetzer<\/a>, VP of Business Development at IMAT Solutions<\/em><\/small><\/p>\n

Top Takeaways<\/h3>\n

\u2022 CMS is shifting Star Ratings toward clinical outcomes<\/strong>, reducing the weight of administrative and process-based measures.
\n\u2022 11 measures are being removed<\/strong>, signaling the end of \u201cbox-checking\u201d as a driver of performance.
\n\u2022 Data quality and clinical accuracy<\/strong> will now directly impact Star Ratings and reimbursement.
\n\u2022 Behavioral health is gaining importance<\/strong>, with new measures like depression screening being introduced.
\n\u2022 Plans must improve real-time data aggregation<\/strong>, normalization, and validation to stay competitive.
\n\u2022 The ability to trust and operationalize data<\/strong> will define success in Medicare Advantage.<\/small><\/p>\n

For Medicare Advantage plans, Star Ratings have always been a critical lever for revenue, performance, and member experience.<\/p>\n

With the Contract Year 2027 Final Rule, CMS is making one thing clear. The rules of the game<\/a> are changing. We are moving away from administrative measurement and toward a model where clinical outcomes and data integrity carry the most weight.<\/p>\n

What is changing in Medicare Advantage Star Ratings under the new CMS rule?<\/h3>\n

The biggest shift is a move away from administrative and process-based measures toward clinical performance.<\/p>\n

CMS finalized the removal of 11 measures that focused on areas like complaints, appeals, call center performance, and member retention. These measures often showed little variation between plans, making them less useful for distinguishing quality.<\/p>\n

In their place, CMS is increasing the emphasis on measures that reflect actual patient outcomes, such as chronic condition management and preventive care.<\/p>\n

This fundamentally changes how plans must approach performance.<\/p>\n

Why did CMS remove 11 Star Ratings measures?<\/h3>\n

\nThe removed measures were not driving meaningful differentiation.<\/p>\n

Most plans were scoring similarly on these metrics, which made it difficult for beneficiaries to compare options. CMS determined that these measures encouraged administrative compliance rather than improved care.<\/p>\n

By removing them, CMS is increasing the statistical weight of clinical measures that better reflect real-world outcomes.<\/p>\n

This is a clear signal that quality will now be judged by what happens to patients, not how efficiently processes are managed.<\/p>\n

How does this shift impact Medicare Advantage plans financially?<\/h3>\n

\nStar Ratings are directly tied to reimbursement, bonus payments, and competitive positioning. By increasing the focus on clinical outcomes, CMS is raising the stakes. Plans that cannot accurately capture and report clinical performance risk losing revenue.<\/p>\n

At the same time, CMS estimates that these changes will increase overall Medicare Trust Fund spending, highlighting how significant the financial impact of Star Ratings continues to be.<\/p>\n

In this environment, performance is no longer just about meeting thresholds. It is about proving outcomes at scale.<\/p>\n

What role does data quality play in Star Ratings performance?<\/h3>\n

\nData quality is now central. Clinical measures depend on structured, accurate, and complete data. If a condition is not coded correctly, or if a lab result is not captured in the right format, it may not count toward performance. <\/p>\n

This creates a major challenge.<\/p>\n

Clinical data is often fragmented across provider systems, inconsistently coded, and not aligned with reporting requirements. Without normalization and validation, even high-quality care can appear as poor performance. In this new model, data quality directly affects outcomes.<\/p>\n

How does the new rule impact health equity and population insights?<\/h3>\n

\nCMS made a notable decision to reverse the planned Health Equity Index reward factor and retain the historical reward structure.<\/p>\n

While this simplifies scoring, it places more responsibility on plans to demonstrate performance across their entire population.<\/p>\n

To do that, plans still need to stratify data by demographic and clinical factors. Without a strong data foundation, it becomes difficult to identify disparities or improve outcomes for specific groups.<\/p>\n

Visibility into the full population remains essential.<\/p>\n

What operational changes must Medicare Advantage plans make?<\/h3>\n

\nPlans need to rethink how they manage data.<\/p>\n

The shift to clinical measures requires:
\n\u2022 Aggregating<\/strong> data from multiple provider systems.
\n\u2022 Normalizing<\/strong> clinical and claims data into consistent formats.
\n\u2022 Validating<\/strong> data before it is used for reporting.
\n\u2022 Monitoring<\/strong> performance continuously, not just at submission. <\/p>\n

Manual processes and fragmented systems cannot support this level of complexity.
\nThis is where many organizations struggle.<\/p>\n

How does this connect to broader CMS digital transformation efforts?<\/h3>\n

\nThe Star Ratings overhaul is part of a larger shift.<\/p>\n

CMS is aligning quality programs around digital measurement, interoperability, and standardized data frameworks. This includes increasing reliance on electronic clinical quality measures and FHIR-based data exchange.<\/p>\n

At the same time, CMS is reducing administrative burden in other areas, such as eliminating unnecessary reporting requirements and streamlining processes.<\/p>\n

The direction is clear. Healthcare is moving toward a digital, data-driven model of quality.<\/p>\n

How can Medicare Advantage plans improve Star Ratings in this new environment?<\/h3>\n

\nSuccess starts with data.<\/p>\n

Plans need to move beyond fragmented reporting and build a unified data foundation that supports both measurement and care delivery.<\/p>\n

This includes:<\/strong><\/p>\n

\u2022 Real-time ingestion of clinical data from provider systems.
\n\u2022 Alignment with standardized reporting formats.
\n\u2022 Integration of clinical and claims data.
\n\u2022 Continuous visibility into care gaps and performance. <\/p>\n

When data is trusted and actionable, plans can shift from reactive reporting to proactive improvement.<\/p>\n

What is the biggest takeaway for healthcare leaders?<\/h3>\n

\nThe Star Ratings overhaul is not just a policy update. It is a signal. CMS is redefining quality around outcomes and data integrity.<\/p>\n

Plans that continue to rely on administrative processes will struggle. Those that invest in clean, connected, and validated data will have a clear advantage. Because in this new model, performance is only as strong as the data behind it.<\/p>\n

How IMAT Supports Medicare Advantage Plans in the New Star Ratings Environment<\/h3>\n

\nAs Star Ratings shift toward clinical outcomes, the ability to aggregate, validate, and act on data becomes critical.<\/p>\n

IMAT helps Medicare Advantage plans move beyond fragmented reporting<\/a> by creating a unified, trusted data foundation. Through real-time ingestion of clinical data from provider EHRs, IMAT enables plans to capture more complete and timely information across their member population.<\/p>\n

That data is then normalized and validated to align with CMS and NCQA reporting requirements, helping ensure that clinical activity is accurately reflected in quality measures and HEDIS reporting<\/a>.<\/p>\n

With a validated data stream and continuous visibility into performance, plans can identify care gaps earlier, improve member outcomes, and strengthen Star Ratings over time.<\/p>\n

In a model where outcomes drive performance, the ability to trust and operationalize data is what ultimately makes the difference.<\/p>\n

Contact IMAT Solutions<\/a> to learn how IMAT Intelligence<\/a> can help you build a trusted data foundation to improve Star Ratings performance.<\/strong><\/p>\n

 <\/p>\n

\n

About the Author<\/strong>
\nMark Coetzer is VP of Business Development at IMAT Solutions, with more than 30 years of technology experience and a decade dedicated to healthcare. He brings deep expertise in clinical data integration, interoperability, and population health, and is passionate about helping organizations build trusted data foundations for better care and smarter outcomes.<\/small><\/p>\n

Additional Insights from Mark Coetzer<\/strong>
\n\u2022 PODCAST: Why HEDIS 2030 Is a \u201cNow\u201d Problem for Payers<\/a>
\n\u2022 What Senior Quality Leaders Must Do Now to Prepare for Digital HEDIS<\/a>
\n\u2022 Meeting the HEDIS 2030 Moment: Why Data Readiness Can No Longer Wait<\/a>
\n\u2022 Why AI Ready Data Drives Sustainable Quality Performance for Health Plans<\/a>
\n\u2022 How to Address Medicare Advantage Care Quality Issues<\/a>
\n\u2022 Real-Time Monitoring of Medicare Advantage Star Ratings Throughout the Year<\/a><\/small><\/p>\n","protected":false},"excerpt":{"rendered":"

By Mark Coetzer, VP of Business Development at IMAT Solutions Top Takeaways \u2022 CMS is shifting Star Ratings toward clinical outcomes, reducing the weight of administrative and process-based measures. \u2022 11 measures are being removed, signaling the end of \u201cbox-checking\u201d as a driver of performance. \u2022 Data quality and clinical accuracy will now directly impact Star Ratings and reimbursement. \u2022 Behavioral health is gaining importance, with new measures like depression screening being introduced. \u2022 Plans…<\/p>\n","protected":false},"author":8,"featured_media":89533,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[221,267],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/imatsolutions.com\/index.php\/wp-json\/wp\/v2\/posts\/89526"}],"collection":[{"href":"https:\/\/imatsolutions.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/imatsolutions.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/imatsolutions.com\/index.php\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/imatsolutions.com\/index.php\/wp-json\/wp\/v2\/comments?post=89526"}],"version-history":[{"count":6,"href":"https:\/\/imatsolutions.com\/index.php\/wp-json\/wp\/v2\/posts\/89526\/revisions"}],"predecessor-version":[{"id":89532,"href":"https:\/\/imatsolutions.com\/index.php\/wp-json\/wp\/v2\/posts\/89526\/revisions\/89532"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/imatsolutions.com\/index.php\/wp-json\/wp\/v2\/media\/89533"}],"wp:attachment":[{"href":"https:\/\/imatsolutions.com\/index.php\/wp-json\/wp\/v2\/media?parent=89526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/imatsolutions.com\/index.php\/wp-json\/wp\/v2\/categories?post=89526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/imatsolutions.com\/index.php\/wp-json\/wp\/v2\/tags?post=89526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}